Literature DB >> 24426869

First time myocardial infarction in a rheumatic patient after elective arthroplasty.

James J Calloway1, Susan M Goodman1, Wesley Hollomon1, Linda A Russell1, Daniel Krauser2.   

Abstract

The management of perioperative cardiovascular risk in patients with rheumatoid arthritis (RA) is challenging due to the independent contribution to risk by high grade inflammatory mechanisms and the underestimation of risk by traditional cardiac risk factors alone. RA is associated with accelerated rates of subclinical atherosclerosis and markedly higher rates of both myocardial infarction and sudden cardiac death over non-RA controls. There is an absence of prospectively validated perioperative coronary heart disease (CHD) risk assessment tools for this unique patient population and available guidelines may fail to identify those patients most at risk. We examine a singular case of first time myocardial infarction after uncomplicated elective surgery in an adult RA patient with an unrevealing preoperative cardiac assessment. We also review the current literature for shared pathogenic mechanisms between systemic inflammation and atherosclerosis, discuss clinical and biologic markers such as C-reactive protein (CRP) in RA patients associated with heightened cardiac risk and discuss recommendations based on available evidence for cardiovascular risk management in this at risk cohort.

Entities:  

Keywords:  C-reactive protein (CRP); coronary heart disease (CHD); rheumatoid arthritis (RA)

Year:  2013        PMID: 24426869      PMCID: PMC3757475          DOI: 10.1007/s11420-012-9309-5

Source DB:  PubMed          Journal:  HSS J        ISSN: 1556-3316


  28 in total

Review 1.  Perioperative care for patients with rheumatic diseases.

Authors:  Bharath M Akkara Veetil; Tim Bongartz
Journal:  Nat Rev Rheumatol       Date:  2011-11-15       Impact factor: 20.543

2.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

Review 3.  2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery.

Authors:  Lee A Fleisher; Joshua A Beckman; Kenneth A Brown; Hugh Calkins; Elliot L Chaikof; Kirsten E Fleischmann; William K Freeman; James B Froehlich; Edward K Kasper; Judy R Kersten; Barbara Riegel; John F Robb
Journal:  J Am Coll Cardiol       Date:  2009-11-24       Impact factor: 24.094

4.  Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.

Authors:  Daniel H Solomon; Elizabeth W Karlson; Eric B Rimm; Carolyn C Cannuscio; Lisa A Mandl; JoAnn E Manson; Meir J Stampfer; Gary C Curhan
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

5.  Pulmonary injury in patients undergoing complex spine surgery.

Authors:  Michael K Urban; Kethy M Jules-Elysee; James B Beckman; Khillil Sivjee; Thomas King; Webster Kelsey; Oheneba Boachie-Adjei
Journal:  Spine J       Date:  2005 May-Jun       Impact factor: 4.166

6.  Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging.

Authors:  Z A Fayad; V Fuster; J T Fallon; T Jayasundera; S G Worthley; G Helft; J G Aguinaldo; J J Badimon; S K Sharma
Journal:  Circulation       Date:  2000-08-01       Impact factor: 29.690

7.  To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial.

Authors:  A Oscarsson; A Gupta; M Fredrikson; J Järhult; M Nyström; E Pettersson; B Darvish; H Krook; E Swahn; C Eintrei
Journal:  Br J Anaesth       Date:  2010-03       Impact factor: 9.166

8.  Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis.

Authors:  Jeffrey D Greenberg; Joel M Kremer; Jeffrey R Curtis; Marc C Hochberg; George Reed; Peter Tsao; Michael E Farkouh; Adeel Nasir; Soko Setoguchi; Daniel H Solomon
Journal:  Ann Rheum Dis       Date:  2010-11-24       Impact factor: 19.103

9.  Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.

Authors:  David W McCarey; Iain B McInnes; Rajan Madhok; Rosie Hampson; Olga Scherbakov; Ian Ford; Hilary A Capell; Naveed Sattar
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

10.  The one year incidence of postoperative myocardial infarction in an orthopedic population.

Authors:  M K Urban; K Jules-Elysee; C Loughlin; W Kelsey; E Flynn
Journal:  HSS J       Date:  2007-12-11
View more
  1 in total

Review 1.  [Perioperative management of patients with rheumatoid arthritis].

Authors:  M Müller; W Pippi-Ludwig
Journal:  Anaesthesist       Date:  2014-11       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.